Critical Pharmaceuticals
HomeCompany ProfileNewsTechnologyManagement TeamPipelineEventsContact Us

Latest News

13th March 2008
  Critical Pharmaceuticals Wins Grant to Assess Novel Absorption Enhancer for Nasal Drug Delivery
24th January 2008
  Critical Pharmaceuticals Wins Two BBSRC CASE Awards
31st March 2008
  Critical Pharmaceuticals Invited to Present at the Controlled Release Society’s Conference 2008
25th June 2008
  Professor Howdle Meets the Duke of Kent
Technology
  Technology
  Critical Pharmaceuticals uses its supercritical fluid technologies to encapsulate drugs within biodegradable polymers for controlled release applications. In a low temperature, single step, solvent free process we can make injectable microparticles, implants and fibrous materials that constantly release the drug over weeks to months.



 
 

 

Events

Event Date / Location More Info.
Controlled Release Society
35th Annual Meeting and
Exposition
12th-16th July 2008
New York, USA
Sunday 13th July
at 13.25 - Soapbox presentation.
Monday 14th July
at 17.30 - Podium presentation, Protein and Peptide Delivery Session, "In vitro and In vivo Testing of CriticalMix™ SR hGH"
Tuesday 15th July
Poster Session II, two posters – CriticalMix™ SR Risperidone and NanoMix™ Single Shot Vaccines.
Tuesday 15th July
10.00 – 11.30 Vaccines Podium Session

BioProcess UK
Annual Conference
28th-29th November 2007
Cardiff, UK.
Dr Andy Lewis, Head of Formulation Development presenting on, "The Supercritical Solution: Controlled Release Biologics"

BioProcess UK Formulation
Special Interest Group
25th October 2007
Covance, Harrogate, UK
Dr Andy Lewis, Head of Formulation Development presenting on, "Sustained Release Biologics: A Case Study"

Recent Appointees in
Polymer Science (RAPS)
19th to 21st
September 2007
Jesus College, Cambridge, UK
Dr Andy Naylor, Head of Process Development presenting, "Development and Scale up of Supercritical Fluid Polymer Processing Equipment."

British Pharmaceutical Conference (BPC) 10th-12th September 2007
Manchester, UK.
Dr Andy Lewis, Head of Formulation Development presenting during APSGB Therapeutic Biomolecules and Vaccines Session, "Risk Mitigation in Formulation Development."

APSGB New Scientists Group 27th April 2007
Pfizer, Sandwich, UK.
Dr Andy Lewis Head of Formulation Development presenting.